Literature DB >> 21642958

Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.

Evelyne Lima-Fernandes1, Hervé Enslen, Emeline Camand, Larissa Kotelevets, Cédric Boularan, Lamia Achour, Alexandre Benmerah, Lucien C D Gibson, George S Baillie, Julie A Pitcher, Eric Chastre, Sandrine Etienne-Manneville, Stefano Marullo, Mark G H Scott.   

Abstract

The tumour suppressor PTEN (phosphatase and tensin deleted on chromosome 10) regulates major cellular functions via lipid phosphatase-dependent and -independent mechanisms. Despite its fundamental pathophysiological importance, how PTEN's cellular activity is regulated has only been partially elucidated. We report that the scaffolding proteins β-arrestins (β-arrs) are important regulators of PTEN. Downstream of receptor-activated RhoA/ROCK signalling, β-arrs activate the lipid phosphatase activity of PTEN to negatively regulate Akt and cell proliferation. In contrast, following wound-induced RhoA activation, β-arrs inhibit the lipid phosphatase-independent anti-migratory effects of PTEN. β-arrs can thus differentially control distinct functional outputs of PTEN important for cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642958      PMCID: PMC3155309          DOI: 10.1038/emboj.2011.178

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Gavin P Robertson; Donalyn Scheuner; Randal J Kaufman; Maria-Magdalena Georgescu; Antonis E Koromilas
Journal:  Sci Signal       Date:  2009-12-22       Impact factor: 8.192

2.  beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.

Authors:  Cédric Boularan; Mark G H Scott; Karima Bourougaa; Myriam Bellal; Emmanuel Esteve; Alain Thuret; Alexandre Benmerah; Marc Tramier; Maité Coppey-Moisan; Catherine Labbé-Jullié; Robin Fåhraeus; Stefano Marullo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-05       Impact factor: 11.205

3.  Tenets of PTEN tumor suppression.

Authors:  Leonardo Salmena; Arkaitz Carracedo; Pier Paolo Pandolfi
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

4.  Autophosphorylation-independent and -dependent functions of focal adhesion kinase during development.

Authors:  Jean-Marc Corsi; Christophe Houbron; Pierre Billuart; Isabelle Brunet; Karine Bouvrée; Anne Eichmann; Jean-Antoine Girault; Hervé Enslen
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

5.  Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.

Authors:  Timothy T Li; Mistre Alemayehu; Adel I Aziziyeh; Cynthia Pape; Macarena Pampillo; Lynne-Marie Postovit; Gordon B Mills; Andy V Babwah; Moshmi Bhattacharya
Journal:  Mol Cancer Res       Date:  2009-07       Impact factor: 5.852

Review 6.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling.

Authors:  Ping Song; Miao Zhang; Shuangxi Wang; Jian Xu; Hyoung Chul Choi; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

Review 8.  Regulation of RhoGEF proteins by G12/13-coupled receptors.

Authors:  Sandra Siehler
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

9.  A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN.

Authors:  Meghdad Rahdar; Takanari Inoue; Tobias Meyer; Jin Zhang; Francisca Vazquez; Peter N Devreotes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

10.  Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control.

Authors:  Anahi Molla-Herman; Cedric Boularan; Rania Ghossoub; Mark G H Scott; Anne Burtey; Marion Zarka; Sophie Saunier; Jean-Paul Concordet; Stefano Marullo; Alexandre Benmerah
Journal:  PLoS One       Date:  2008-11-14       Impact factor: 3.240

View more
  27 in total

Review 1.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

2.  Arresting times for PTEN.

Authors:  Miles D Houslay
Journal:  EMBO J       Date:  2011-07-06       Impact factor: 11.598

Review 3.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 4.  PTEN at a glance.

Authors:  Yuji Shi; Benjamin E Paluch; Xinjiang Wang; Xuejun Jiang
Journal:  J Cell Sci       Date:  2012-10-15       Impact factor: 5.285

Review 5.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

6.  Non-visual arrestins regulate the focal adhesion formation via small GTPases RhoA and Rac1 independently of GPCRs.

Authors:  Whitney M Cleghorn; Nada Bulus; Seunghyi Kook; Vsevolod V Gurevich; Roy Zent; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2017-11-11       Impact factor: 4.315

7.  The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.

Authors:  Elodie Blondel-Tepaz; Marie Leverve; Badr Sokrat; Justine S Paradis; Milena Kosic; Kusumika Saha; Cédric Auffray; Evelyne Lima-Fernandes; Alessia Zamborlini; Anne Poupon; Louis Gaboury; Jane Findlay; George S Baillie; Hervé Enslen; Michel Bouvier; Stéphane Angers; Stefano Marullo; Mark G H Scott
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

8.  PTEN-mediated ERK1/2 inhibition and paradoxical cellular proliferation following Pnck overexpression.

Authors:  Tushar B Deb; Robert J Barndt; Annie H Zuo; Surojeet Sengupta; Christine M Coticchia; Michael D Johnson
Journal:  Cell Cycle       Date:  2014-01-20       Impact factor: 4.534

Review 9.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

10.  The Arf GAP AGAP2 interacts with β-arrestin2 and regulates β2-adrenergic receptor recycling and ERK activation.

Authors:  Yuanjun Wu; Yu Zhao; Xiaojie Ma; Yunjuan Zhu; Jaimin Patel; Zhongzhen Nie
Journal:  Biochem J       Date:  2013-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.